Closes Oct 15, 2027
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide